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Abstract
• Healthy articular cartilage protects and provides smooth
functioning of the joint. The deterioration of the articular cartilage
leads to the crippling disease known as osteoarthritis (OA).
• OA is a leading cause of disability in the United States. Although
some of the current treatment modalities, along with
pharmacological treatment, may offer short term improvement
with pain and function, they do not offer long term relief, and are
ineffective in preventing the progression of OA.
• In advanced stages, surgery in the form of total knee arthroplasty
(TKA), is sometimes needed. This is an invasive procedure and
typically requires hospitalization.
• Now, there is a safe and effective modality on the horizon. This
minimally invasive treatment is the injection of mesenchymal stem
cells (MSCs) directly into the affected joint.
• These are multipotent progenitor cells that offer
immunosuppressive and anti-inflammatory action, have the
capacity of self-renewal, and have high plasticity. MSCs can be
harvested from the patient themselves, autologous, or can be from
a donor, allogeneic.
• A review of the literature suggests treatment of moderate to severe
OA of the knee with MSC injections are a viable treatment option
when compared to other treatments that include a total knee
replacement. MSC s are the only treatment option that have
evidence of cartilage regeneration in addition to improvement of
functional mobility, pain relief, and overall improvement in quality
of life.

Introduction
• Osteoarthritis (OA) is a leading cause of joint disease characterized
by the degeneration of articular cartilage. OA leads to pain,
stiffness, swelling, tenderness, and loss of mobility and flexibility
in the affected joint. These symptoms lead to reduced activity,
which leads to weight gain, which worsens OA. (Burke, et al.
2016). There is no cure for this disease.
• Most treatments are short lived, and only offer little relief. For
severe OA, surgical treatment, such as total knee arthroplasty
(TKA), may offer longer relief, however, this procedure is invasive,
requires hospitalization, causes moderate to severe pain, and has
risks for infection and failure.
• According to new research, a promising treatment could be on the
horizon.
• The newest treatment that is being researched for the treatment of
moderate to severe OA is mesenchymal stem cell injections.
When compared to TKA surgery, this treatment is much less
invasive, has a much quicker recovery time, less chance for
adverse events, and is much less expensive

Cont. Literature Review

Statement of the Problem
• Current treatments for OA such as weight loss, physical therapy,
and pharmaceuticals help lessen the pain and increase mobility in
cases of mild to moderate OA. In severe cases, the standard of
care in the U.S. is TKA. Although effective in most cases, the
procedure itself is invasive, has the potential for failure and
infection, is costly, and still takes several weeks for rehabilitation.

Cost comparison of treatments used for osteoarthritis:
 The average cost of TKA is $49,500 for uninsured patients
(Greengard 2015).
 MSC injections for OA is currently under research and is not
covered by insurance. It is estimated at $3,000-$3,500 to inject one
joint and $4,000-$5,000 for two joints (Dr. Robert J. Daley, n.d.).

Research Question
• In patients with moderate to severe osteoarthritis, could
mesenchymal stem cell injections, compared to current
treatments, offer longer pain relief and improved function?
• In patients with severe osteoarthritis, is treatment with
mesenchymal stem cells, compared to total knee arthroplasty, less
expensive?
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Literature Review
Pathophysiology of osteoarthritis:
• Proper, non-painful joint function in the human body is dependent
upon the wellness of the articular cartilage that covers the
opposing articulating bones. Deterioration of the articular cartilage
leads to the crippling disease known as OA (Correa and Lietman,
in press).
• Patients with OA experience loss of flexibility, stiffness, swelling
and pain, leading to loss of mobility which leads to weight gain,
which is worse on OA affected joints (Burke et al. 2016).
• OA also involves structures such as subchondrial bone, synovial
fluid, and the synovial membrane, causes hypertrophic bone
changes with osteophyte formation and subchondrial bone
remodeling (Pearle et al. 2005).
Current treatments for osteoarthritis:
• Aquatic exercises improved pain symptoms, but only for a short
term following conclusion of treatment (Bartels et al. 2016).
• Land based physical therapy results in pain reduction and
improved function and quality of life for up to 6 months following
the completion of the program (Fransen et al.2015).
• Intra-articular corticosteroid injections showed improvement with
function for up to 6 weeks and pain relief for up to 13 weeks post
injection (Jüni et al. 2015).
• Viscosupplementation injection in the knee with hyaluronan
showed significant improvement with pain and function up to 13
weeks post injection (Bellamy et al. 2005).
 Total knee arthtoplasty (TKA) leads to reduction in pain,
improvement of function, and better quality of life for treatment of
severe OA (Singh et al. 2013).
Mesenchymal stem cells for treatment of osteoarthritis:
 Recent evidence suggests that MSC injection can boost repair and
limit further destruction of joint (Diekman and Guilak, 2013).
 MSC injection significantly improves cartilage quality resulting in
pain relief and improved quality of life (Mehrabani et al. 2016).
 MSC sheet implantation show greater efficacy over MSC injections
in promoting meniscus regeneration while inhibiting progression
of OA (Qi et al. 2016).
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Improvement in pain by treatment.
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Applicability to Clinical
Practice
• Clinicians are taught to always have their patients best interest in
mind. For treatment of OA, there are many different conservative
choices such as land and water exercise therapy, electromagnetic
therapy, oral pain medications, and injectable steroids to name a
few, that are non-invasive and inexpensive, however, they each
have a varying degree of success with pain control, functional
improvement, and improvement in quality of life, but none show
regenerative properties for the cartilage that is damaged.
• Based on moderate quality of evidence, treatment of OA, mostly in
the knee, with mesenchymal stem cell injections, are the only
option that show regeneration of cartilage. This leads to
improvement of functional mobility, pain relief, and overall
improvement in quality of life.
• When compared to a TKA, which is the current standard of care for
severe OA, it is minimally invasive, less painful, has minimal
associated risks, requires less rehabilitation time, and causes a lower
burden of cost on the health care system.
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